Malka Cohen-Armon
The Neufeld Cardiac Research Institute
Department of Physiology and Pharmacology
Sackler Faculty of Medicine
Tel-Aviv University
Israel
Name/email consistency: high
- A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells. Castiel, A., Visochek, L., Mittelman, L., Dantzer, F., Izraeli, S., Cohen-Armon, M. BMC. Cancer (2011)
- DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Cohen-Armon, M., Visochek, L., Rozensal, D., Kalal, A., Geistrikh, I., Klein, R., Bendetz-Nezer, S., Yao, Z., Seger, R. Mol. Cell (2007)
- PARP-1 activation in the ERK signaling pathway. Cohen-Armon, M. Trends Pharmacol. Sci. (2007)
- Long-term memory requires polyADP-ribosylation. Cohen-Armon, M., Visochek, L., Katzoff, A., Levitan, D., Susswein, A.J., Klein, R., Valbrun, M., Schwartz, J.H. Science (2004)